Pepa Patricia A, Lee Kelly C, Huynh Hien E, Wilson Michael P
Department of Pharmacy, UC San Diego Health, San Diego, California.
UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California.
J Emerg Med. 2017 Oct;53(4):530-535. doi: 10.1016/j.jemermed.2017.05.028.
Acute agitation in the setting of alcohol intoxication is commonly encountered in the Emergency Department (ED). In this setting, expert consensus guidelines recommend haloperidol over second-generation antipsychotics due to their limited safety data in alcohol intoxication.
The primary objective was to compare vital sign changes prior to and after risperidone administration between ED patients presenting with alcohol intoxication [ETOH (+)] and without alcohol intoxication [ETOH (-)]. The secondary objective was to assess the effect of benzodiazepine co-administration with risperidone on vital signs.
This was a retrospective chart review of patients who received oral risperidone for acute agitation at two university EDs between January 1, 2012 and December 31, 2015. Vital signs (oxygen saturation, systolic and diastolic blood pressure, heart rate, and respiratory rate) were compared in patients who had ingested alcohol with those who had not.
There were 785 patients without evidence of alcohol intoxication who received risperidone in the ED, and 52 patients with alcohol intoxication who received risperidone. Overall, risperidone with and without alcohol intoxication and benzodiazepine administration had no statistically significant effect on vital signs (p = ns for all comparisons).
This study suggests that oral risperidone may be a safe option for acute agitation in patients presenting to the ED with alcohol intoxication.
急诊科(ED)经常遇到酒精中毒引发的急性激越状态。在此情况下,由于第二代抗精神病药物在酒精中毒方面的安全性数据有限,专家共识指南推荐使用氟哌啶醇而非第二代抗精神病药物。
主要目的是比较酒精中毒[ETOH(+)]和无酒精中毒[ETOH(-)]的急诊科患者在服用利培酮前后的生命体征变化。次要目的是评估苯二氮䓬类药物与利培酮联合使用对生命体征的影响。
这是一项对2012年1月1日至2015年12月31日期间在两所大学急诊科因急性激越状态接受口服利培酮治疗的患者进行的回顾性病历审查。比较了饮酒患者和未饮酒患者的生命体征(血氧饱和度、收缩压和舒张压、心率和呼吸频率)。
急诊科有785例无酒精中毒证据的患者接受了利培酮治疗,52例酒精中毒患者接受了利培酮治疗。总体而言,无论有无酒精中毒以及是否使用苯二氮䓬类药物,利培酮对生命体征均无统计学意义上的显著影响(所有比较p =无显著性差异)。
本研究表明,对于因酒精中毒就诊于急诊科的患者,口服利培酮可能是治疗急性激越状态的安全选择。